Patient Assistance Program

Valeant Pharmaceuticals understands that some patients may face financial obstacles that keep them from obtaining the prescription products they need. Valeant is committed to improving patient care through our patient assistance programs. These programs are listed below:

Valeant Patient Assistance Program (Valeant PAP)

833-862-VPAP (833-862-8727)

 

FOR BAUSCH + LOMB PRODUCTS

ALREX® (loteprednol etabonate ophthalmic suspension) 0.2%

BEPREVE® (bepotastine besilate ophthalmic solution) 1.5%

BESIVANCE® (besifloxacin ophthalmic suspension) 0.6%

LACRISERT® (hydroxypropyl cellulose ophthalmic insert)

LOTEMAX® (loteprednol etabonate ophthalmic gel) 0.5%

MACUGEN® (pegaptanib sodium injection) intravitreal injection

PROLENSA® (bromfenac ophthalmic solution) 0.07%

RETISERT® (fluocinolone acetonide intravitreal implant) 0.59 mg for intravitreal use

TIMOPTIC® in OCUDOSE® (timolol maleate ophthalmic solution), 0.25% or 0.5%

VISUDYNE® (verteporfin for injection), for intravenous use

ZIRGAN® (ganciclovir ophthalmic gel) 0.15%

ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension)

 

FOR ORTHO DERMATOLOGICS PRODUCTS

ACANYA® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%, for topical use

CARAC® (fluorouracil cream) Cream, 0.5%

CLINDAGEL® (clindamycin phosphate gel) topical gel, 1%

ELIDEL® (pimecrolimus) Cream, 1% for topical use

JUBLIA® (efinaconazole) topical solution, 10%, 4 mL or 8 mL

LOCOID® (hydrocortisone butyrate) Lotion, 0.1%, for topical use

LUZU® (luliconazole) Cream, 1% for topical use

NORITATE® (metronidazole cream) Cream, 1% for topical use only

ONEXTON® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/3.75% for topical use

RENOVA® (tretinoin cream) 0.02% for topical use, pump

RETIN-A MICRO® (tretinoin) Gel microsphere, 0.08% for topical use

SOLODYN® (minocycline HCI) extended release tablets for oral use, 55 mg, 80 mg or 105 mg

ZYCLARA® (lmiquimod) cream 3.75%, for topical use, 7.5 g pump or box of 28 packets

 

FOR SALIX PHARMACEUTICALS PRODUCTS

APRISO® (mesalamine) extended-release capsules

CYCLOSET® (bromocriptine mesylate tablets), for oral use

MOVIPREP® (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate,

    and ascorbic acid for oral solution)

RELISTOR® (methylnaltrexone bromide) tablets, for oral use, 90-count

RELISTOR® (methylnaltrexone bromide) injection, for subcutaneous use (7 single-dose pre-filled syringes per carton),

    8 mg/0.4 mL or 12 mg/0.6 mL

UCERIS® (budesonide) Extended Release Tablets, for oral use

UCERIS® (budesonide) rectal foam

XIFAXAN® (rifaximin) Tablets, for oral use, 550 mg

 

FOR VALEANT PHARMACEUTICALS PRODUCTS

ANCOBON® (flucytosine) 500 mg Capsules             

ANDROID® (C-III) (methylTESTOSTERone Capsules, USP) 10 mg

CUPRIMINE® (penicillamine) Capsules

DEMSER® (metyrosine) Capsules

LODOSYN® (carbidopa) tablets                       

MEPHYTON® (phytonadione) Vitamin K, tablets                           

OXSORALEN-ULTRA® Capsules (methoxsalen capsules, USP, 10 mg)   

SYPRINE® (trientine hydrochloride) capsules

TARGRETIN® (bexarotene) capsules, for oral use

TARGRETIN® (bexarotene) Gel 1%

TASMAR® (tolcapone) Tablets                      

ZELAPAR® (selegiline hydrochloride) Orally Disintegrating Tablets                    

 

Don’t See Your Prescribed Product Listed?

Not every Valeant prescription product is included in the Valeant PAP. The Valeant PAP is also subject to change at any time without prior notification. Call us at 833-862-VPAP (833-862-8727), 8 AM to 5 PM ET for more information.

 

Siliq Solutions™ Patient Assistance Program

855-RX-SILIQ (855-797-4547)

SILIQ™ (brodalumab) injection, for subcutaneous use, 210 mg/1.5 mL solution

VNP.0061.USA.17